Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04978571Not ApplicableRecruiting

Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)

Role: collaborator

NCT04428619Not ApplicableCompleted

Percutaneous Electrical Nerve Field Stimulation for Adults With Irritable Bowel Syndrome

Role: collaborator

NCT04162145Not ApplicableTerminated

BRIDGE Device for Treatment of Opioid Withdrawal

Role: collaborator

NCT02673684Not ApplicableTerminated

Effects of Neuro-Stim System on Pain, Sleep, and Opioid Use

Role: collaborator

All 4 trials loaded